Cambridge, UK — Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its sales distribution agreement with industry-leading European distributor, CliniSciences. With a diverse portfolio of companies operating across Europe, CliniSciences is well-positioned to serve the needs of European customers wanting to purchase Qkine proteins. CliniSciences boasts an impressive network of […]
CAMBRIDGE, UK – bit.bio’s human induced pluripotent stem cell (hiPSC)-derived ioMicroglia™ provide a consistently functional and rapid human in vitro model for the study of neuroinflammation and neurodegenerative diseases such as Alzheimer’s disease. Recapitulating key human microglia functions, ioMicroglia can mediate inflammatory responses, dispose of unwanted materials, and carry out immune surveillance. In the body, microglia are integral to […]
Investment to expand cell line development capabilities and accelerate customer workflows, as part of its diverse and tailored antibody solutions Cambridge, UK, and Porto, Portugal: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the Cyto-Mine® platform has been selected by FairJourney Biologics, a world leading end-to-end antibody partner, providing […]
Singapore: A*STAR’s Genome Institute of Singapore (GIS), NanoString® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response. The new lab, called the SpACE-Dx lab (Spatial Atlas of Clinical Evolution of Disease), […]
BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash. Bruker announced the agreement to acquire PhenomeX on August 17, 2023. PhenomeX is a functional cell biology company that provides single-cell biology research tools to deliver […]
In 2021, AcouSort AB (publ) (”AcouSort”, “the Company”) received funding from Vinnova for the project IndiCell. The aim of the project is to enable the transfer of novel stem cell treatments from research to a clinical setting. The project is planned to run over five years and generate revenues of SEK 1.25 million to AcouSort. […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE […]
Saint-Sulpice, Switzerland Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal testing, is thrilled to announce the successful closure of its Series A funding round. The company has secured an oversubscribed 12.4M CHF investment from top-tier venture capital firms across Europe, co-led by Swisscanto and imec.xpand, together […]
Kusatsu/Shiga, Japan – Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS (“Telethon”) (https://www.telethon.it/en), Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®. Under this agreement, Takara Bio provides Telethon with reliable supplies of RetroNectin®.The technologies licensed to Telethon are based on […]
Today, LGC announced the appointment of David P. King as Non-Executive Chairman of its Board of Directors. Euan O’Sullivan, President & Chief Executive Officer (CEO) of LGC said: “We are delighted to welcome David to LGC’s Board of Directors, given his extensive healthcare experience within the diagnostics, pharmaceutical and biotech sectors, key customer focus areas […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
